Further Reading

Research supporting the 14 point plan

1. Wong CH, Samuel M, Tan BK, Song C. Capsular contracture in subglandular breast augmentation with textured versus smooth breast implants: a systematic review. Plast. Reconstr. Surg. 2006;118(5):1224-1236.

2. Bengtson BP, Van Natta BW, Murphy DK, Slicton A, Maxwell GP, Style USCCSG. Style 410 highly cohesive silicone breast implant core study results at 3 years. Plast. Reconstr. Surg. 2007;120(7 Suppl 1):40S-48S.

3. Spear SL, Murphy DK, Slicton A, Walker PS, Inamed Silicone Breast Implant USSG. Inamed silicone breast implant core study results at 6 years. Plast. Reconstr. Surg. 2007;120(7 Suppl 1):8S-16S; discussion 17S-18S.

4. Chong SJ, Deva AK. Understanding the Etiology and Prevention of Capsular Contracture: Translating Science into Practice. Clin. Plast. Surg. 2015;42(4):427-436.

5. Deva AK, Adams WP, Vickery K. The role of bacterial biofilms in Device-Associated Infection. Plast. Reconstr. Surg. 2013;132:1319-1328.

6. Hall-Stoodley L, Costerton JW, Stoodley P. Bacterial biofilms: from the natural environment to infectious diseases. Nat. Rev. Microbiol. 2004;2(2):95-108.

7. Sauer K, Camper AK, Ehrlich GD, Costerton JW, Davies DG. Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilm. J. Bacteriol. 2002;184(4):1140-1154.

8. Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 2002;15(2):167-193.

9. Fux CA, Costerton JW, Stewart PS, Stoodley P. Survival strategies of infectious biofilms. Trends Microbiol. 2005;13(1):34-40.

10. Hoiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. Antibiotic resistance of bacterial biofilms. Int. J. Antimicrob. Agents. 2010;35(4):322-332.

11. Deva AK, Adams WP, Vickery K. The role of bacterial biofilms in device associated infection. Plast. Reconstr. Surg. 2013;in press.

12. Burkhardt BR, Fried M, Schnur PL, Tofield JJ. Capsules, infection, and intraluminal antibiotics. Plast. Reconstr. Surg. 1981;68(1):43-49.

13. Ahn CY, Ko CY, Wagar EA, Wong RS, Shaw WW. Microbial evaluation: 139 implants removed from symptomatic patients. Plast. Reconstr. Surg. 1996;98(7):1225-1229.

14. Virden CP, Dobke MK, Stein P, Parsons CL, Frank DH. Subclinical infection of the silicone breast implant surface as a possible cause of capsular contracture. Aesthetic Plast. Surg. 1992;16(2):173-179.

15. Pajkos A, Deva AK, Vickery K, Cope C, Chang L, Cossart YE. Detection of subclinical infection in significant breast implant capsules. Plast. Reconstr. Surg. 2003;111(5):1605-1611.

16. Del Pozo JL, Tran NV, Petty PM, et al. Pilot Study of Association of Bacteria on Breast Implants with Capsular Contracture. J. Clin. Microbiol. 2009;47(5):1333-1337.

17. Bartsich S, Ascherman JA, Whittier S, Yao CA, Rohde C. The breast: a clean-contaminated surgical site. Aesthet. Surg. J. 2011;31(7):802-806.

18. Rieger UM, Raschke GF, Frei R, Djedovic G, Pierer G, Trampuz A. Role of bacterial biofilms in patients after reconstructive and aesthetic breast implant surgery. J. Long. Term Eff. Med. Implants. 2014;24(2-3):131-138.

19. Hu H, Jacombs A, Vickery K, Merten SL, Pennington DG, Deva AK. Chronic biofilm infection in breast implants is associated with an increased T-cell lymphocytic infiltrate: implications for breast implant-associated lymphoma. Plast. Reconstr. Surg. 2015;135(2):319-329.

20. Shah Z, Lehman JA, Jr., Tan J. Does infection play a role in breast capsular contracture? Plast. Reconstr. Surg. 1981;68(1):34-42.

21. Kossovsky N, Heggers JP, Parsons RW, Robson MC. Acceleration of capsule formation around silicone implants by infection in a guinea pig model. Plast. Reconstr. Surg. 1984;73(1):91-98.

22. Tamboto H, Vickery K, Deva AK. Subclinical(biofilm) infection causes capsular contracture in a porcine model following augmentation mammaplasty. Plast. Reconstr. Surg. 2010;126:835-842.

23. Jacombs A, Tahir S, Hu H, et al. In vitro and in vivo investigation of the influence of implant surface on the formation of bacterial biofilm in mammary implants. Plast. Reconstr. Surg. 2014;133(4):471e-480e.

24. Hu H, Jacombs A, Vickery K, Merten SL, Pennington DG, Deva AK. Chronic biofilm infection in breast implants is associated with an increased T cell lymphocytic infiltrate – implications for breast implant-associated lymphoma. Plast. Reconstr. Surg. 2015;135(2):319-329.

25. Brody GS, Deapen D, Taylor CR, et al. Anaplastic large cell lymphoma occurring in women with breast implants: analysis of 173 cases. Plast. Reconstr. Surg. 2015;135(3):695-705.

26. Darouiche RO, Meade R, Mansouri MD, Netscher DT. In vivo efficacy of antimicrobe-impregnated saline-filled silicone implants. Plast. Reconstr. Surg. 2002;109(4):1352-1357.

27. Jacombs A, Allan J, Hu H, et al. Prevention of biofilm-induced capsular contracture with antibiotic-impregnated mesh in a porcine model. Aesthet. Surg. J. 2012;32(7):886-891.

28. Adams WP, Jr., Conner WC, Barton FE, Jr., Rohrich RJ. Optimizing breast pocket irrigation: an in vitro study and clinical implications. Plast. Reconstr. Surg. 2000;105(1):334-338; discussion 339-343.

29. Adams WP, Jr., Rios JL, Smith SJ. Enhancing patient outcomes in aesthetic and reconstructive breast surgery using triple antibiotic breast irrigation: six-year prospective clinical study. Plast. Reconstr. Surg. 2006;118(7 Suppl):46S-52S.

30. Blount AL, Martin MD, Lineberry KD, Kettaneh N, Alfonso DR. Capsular contracture rate in a low-risk population after primary augmentation mammaplasty. Aesthet. Surg. J. 2013;33(4):516-521.

31. Giordano S, Peltoniemi H, Lilius P, Salmi A. Povidone-Iodine Combined With Antibiotic Topical Irrigation to Reduce Capsular Contracture in Cosmetic Breast Augmentation: A Comparative Study. Aesthet. Surg. J. 2013;33(5):675-680.

32. Bratzler DW, Houck PM, Surgical Infection Prevention Guideline Writers W. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Am. J. Surg. 2005;189(4):395-404.

33. Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg Infect (Larchmt). 2013;14(1):73-156.

34. Khan UD. Breast augmentation, antibiotic prophylaxis, and infection: comparative analysis of 1,628 primary augmentation mammoplasties assessing the role and efficacy of antibiotics prophylaxis duration. Aesthetic Plast. Surg. 2010;34(1):42-47.

35. Perrotti JA, Castor SA, Perez PC, Zins JE. Antibiotic use in aesthetic surgery: a national survey and literature review. Plast. Reconstr. Surg. 2002;109(5):1685-1693; discussion 1694-1685.

36. Wiener TC. Relationship of incision choice to capsular contracture. Aesthetic Plast. Surg. 2008;32(2):303-306.

37. Jacobson JM, Gatti ME, Schaffner AD, Hill LM, Spear SL. Effect of incision choice on outcomes in primary breast augmentation. Aesthet. Surg. J. 2012;32(4):456-462.

38. Wixtrom RN, Stutman RL, Burke RM, Mahoney AK, Codner MA. Risk of breast implant bacterial contamination from endogenous breast flora, prevention with nipple shields, and implications for biofilm formation. Aesthet. Surg. J. 2012;32(8):956-963.

39. Giordano S, Salmi A. Nipple shields as additional tool to pocket irrigation in reducing capsular contracture after breast augmentation. Plast. Reconstr. Surg. 2014;134(2S):386.

40. Heden P, Bone B, Murphy DK, Slicton A, Walker PS. Style 410 cohesive silicone breast implants: safety and effectiveness at 5 to 9 years after implantation. Plast. Reconstr. Surg. 2006;118(6):1281-1287.

41. Maxwell GP, Van Natta BW, Bengtson BP, Murphy DK. Ten-year results from the Natrelle 410 anatomical form-stable silicone breast implant core study. Aesthet. Surg. J. 2015;35(2):145-155.

42. Handel N, Garcia ME, Wixtrom R. Breast implant rupture: causes, incidence, clinical impact, and management. Plast. Reconstr. Surg. 2013;132(5):1128-1137.

43. Rouault TA. Microbiology. Pathogenic bacteria prefer heme. Science. 2004;305(5690):1577-1578.

44. Burkhardt BR, Eades E. The effect of Biocell texturing and povidone-iodine irrigation on capsular contracture around saline-inflatable breast implants. Plast. Reconstr. Surg. 1995;96(6):1317-1325.

45. Mladick RA. “No-touch” submuscular saline breast augmentation technique. Aesthetic Plast. Surg. 1993;17(3):183-192.

46. Flugstad NA, Pozner JN, Baxter RA, et al. Does Implant Insertion with a Funnel Decrease Capsular Contracture? A Preliminary Report. Aesthet. Surg. J. 2015.

47. Ward WG, Sr., Cooper JM, Lippert D, Kablawi RO, Neiberg RH, Sherertz RJ. Glove and gown effects on intraoperative bacterial contamination. Ann. Surg. 2014;259(3):591-597.

48. Beldame J, Lagrave B, Lievain L, Lefebvre B, Frebourg N, Dujardin F. Surgical glove bacterial contamination and perforation during total hip arthroplasty implantation: when gloves should be changed. Orthop Traumatol Surg Res. 2012;98(4):432-440.

49. Saito Y, Kobayashi H, Uetera Y, Yasuhara H, Kajiura T, Okubo T. Microbial contamination of surgical instruments used for laparotomy. Am. J. Infect. Control. 2014;42(1):43-47.

50. Knobben BA, van der Mei HC, van Horn JR, Busscher HJ. Transfer of bacteria between biomaterials surfaces in the operating room–an experimental study. J. Biomed. Mater. Res. A. 2007;80(4):790-799.

51. Peersman G, Laskin R, Davis J, Peterson MG, Richart T. Prolonged operative time correlates with increased infection rate after total knee arthroplasty. HSS J. 2006;2(1):70-72.

52. Leong G, Wilson J, Charlett A. Duration of operation as a risk factor for surgical site infection: comparison of English and US data. J. Hosp. Infect. 2006;63(3):255-262.

53. Korol E, Johnston K, Waser N, et al. A systematic review of risk factors associated with surgical site infections among surgical patients. PLoS ONE. 2013;8(12):e83743.

54. Grzywna A, Glotzbecker MP, J.B. E. Offset layered closure may reduce wound infections in EOS surgery. Spine Deformity. 2014;2(6):504.

55. Dur AH, den Hartog D, Tuinebreijer WE, Kreis RW, Lange JF. Low recurrence rate of a two-layered closure repair for primary and recurrent midline incisional hernia without mesh. Hernia. 2009;13(4):421-426.

56. Dower R, Turner ML. Pilot study of timing of biofilm formation on closed suction wound drains. Plast. Reconstr. Surg. 2012;130(5):1141-1146.

57. Araco A, Gravante G, Araco F, Delogu D, Cervelli V. Capsular contracture: results of 3002 patients with aesthetic breast augmentation. Plast. Reconstr. Surg. 2006;118(6):1499-1500; author reply 1500-1492.

58. Henriksen TF, Fryzek JP, Holmich LR, et al. Surgical intervention and capsular contracture after breast augmentation: a prospective study of risk factors. Ann. Plast. Surg. 2005;54(4):343-351.

59. Surgeons AAoO. Antibiotic Prophylaxis for Patients after Total Joint Replacement. In: American Academy of Orthopaedic S, ed2009.

60. Hunter JG, Padilla M, Cooper-Vastola S. Late Clostridium perfringens breast implant infection after dental treatment. Ann. Plast. Surg. 1996;36(3):309-312.

61. Knobben BA, van Horn JR, van der Mei HC, Busscher HJ. Evaluation of measures to decrease intra-operative bacterial contamination in orthopaedic implant surgery. J. Hosp. Infect. 2006;62(2):174-180.

62. Adams WP, Jr., Culbertson EJ, Deva AK, et al. Macrotextured Breast Implants with Defined Steps to Minimize Bacterial Contamination around the Device: Experience in 42,000 Implants. Plast Reconstr Surg. 2017;140(3):427-431.

63. Loch-Wilkinson A, Beath KJ, Knight RJW, et al. Breast Implant-Associated Anaplastic Large Cell Lymphoma in Australia and New Zealand: High-Surface-Area Textured Implants Are Associated with Increased Risk. Plast Reconstr Surg. 2017;140(4):645-654.

64. Bhatt AP, Redinbo MR, Bultman SJ. The role of the microbiome in cancer development and therapy. CA Cancer J Clin. 2017;67(4):326-344.

65.Deva AK. Discussion: U.S. Epidemiology of Breast Implant-Associated Anaplastic Large-Cell Lymphoma. Plast Reconstr Surg. 2017;139(5):1051-1052.

66. Kadin ME, Deva A, Xu H, et al. Biomarkers Provide Clues to Early Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma. Aesthet Surg J. 2016;36(7):773-781.